{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:55:13Z","timestamp":1793105713780,"version":"4.5.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"suppl_5","license":[{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Health and Human Services"},{"name":"Office of the Assistant Secretary for Preparedness and Response"},{"DOI":"10.13039\/100012399","name":"Biomedical Advanced Research and Development Authority (BARDA)","doi-asserted-by":"crossref","award":["HHSO100201500013C"],"award-info":[{"award-number":["HHSO100201500013C"]}],"id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals, Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,22]]},"DOI":"10.1093\/infdis\/jiy285","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T15:13:31Z","timestamp":1526656411000},"page":"S612-S626","source":"Crossref","is-referenced-by-count":188,"title":["Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates"],"prefix":"10.1093","volume":"218","author":[{"given":"Kristen E","family":"Pascal","sequence":"first","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Dudgeon","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C","family":"Trefry","sequence":"additional","affiliation":[{"name":"Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Anantpadma","sequence":"additional","affiliation":[{"name":"Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuteru","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D","family":"Murin","sequence":"additional","affiliation":[{"name":"Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah L","family":"Turner","sequence":"additional","affiliation":[{"name":"Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Fairhurst","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Torres","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashique","family":"Rafique","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yan","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Badithe","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Yu","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terra","family":"Potocky","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L","family":"Bixler","sequence":"additional","affiliation":[{"name":"Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor B","family":"Chance","sequence":"additional","affiliation":[{"name":"Pathology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D","family":"Pratt","sequence":"additional","affiliation":[{"name":"Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco D","family":"Rossi","sequence":"additional","affiliation":[{"name":"Center for Aerobiological Sciences, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D","family":"Shamblin","sequence":"additional","affiliation":[{"name":"Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne E","family":"Wollen","sequence":"additional","affiliation":[{"name":"Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine M","family":"Zelko","sequence":"additional","affiliation":[{"name":"Virology Division, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Ricardo","family":"Carrion","sequence":"additional","affiliation":[{"name":"Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Worwa","sequence":"additional","affiliation":[{"name":"Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary M","family":"Staples","sequence":"additional","affiliation":[{"name":"Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darya","family":"Burakov","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9168-2892","authenticated-orcid":false,"given":"Robert","family":"Babb","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Martin","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy T","family":"Huang","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Erlandson","sequence":"additional","affiliation":[{"name":"Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa S","family":"Willis","sequence":"additional","affiliation":[{"name":"Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M","family":"Dreier","sequence":"additional","affiliation":[{"name":"Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B","family":"Ward","sequence":"additional","affiliation":[{"name":"Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Davey","sequence":"additional","affiliation":[{"name":"Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret L M","family":"Pitt","sequence":"additional","affiliation":[{"name":"Office of the Commander, US Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Lipsich","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mason","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Olson","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Stahl","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-2906","authenticated-orcid":false,"given":"Christos A","family":"Kyratsous","sequence":"additional","affiliation":[{"name":"Regeneron Pharmaceuticals, Inc., Tarrytown, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,31]]},"reference":[{"key":"key\n\t\t\t\t2018112203580617700_CIT0001","first-page":"111","article-title":"Ebola and Marburg haemorrhagic fever","volume":"64","author":"Rougeron","year":"2015","journal-title":"J Clin Virol"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0002","first-page":"1360","article-title":"Ebola virus disease complications as experienced by survivors in Sierra Leone","volume":"62","author":"Tiffany","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0003","first-page":"2484","article-title":"Post-Ebola signs and symptoms in U.S. survivors","volume":"373","author":"Epstein","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0004","first-page":"3602","article-title":"The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing","volume":"93","author":"Sanchez","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0005","first-page":"5762","article-title":"Processing of the Ebola virus glycoprotein by the proprotein convertase furin","volume":"95","author":"Volchkov","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0006","first-page":"177","article-title":"Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor","volume":"454","author":"Lee","year":"2008","journal-title":"Nature"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0007","first-page":"340","article-title":"Ebola virus entry requires the cholesterol transporter Niemann-Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0008","first-page":"3","article-title":"The multiple roles of sGP in Ebola pathogenesis","volume":"28","author":"de La Vega","year":"2015","journal-title":"Viral Immunol"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0009","first-page":"S1075","article-title":"Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections","volume":"204","author":"Geisbert","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0010","first-page":"1893","article-title":"Antibodies are necessary for rVSV\/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates","volume":"110","author":"Marzi","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0011","first-page":"857","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0012","first-page":"47","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0013","first-page":"1339","article-title":"Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody","volume":"351","author":"Corti","year":"2016","journal-title":"Science"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0014","first-page":"1078","article-title":"Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak","volume":"351","author":"Bornholdt","year":"2016","journal-title":"Science"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0015","first-page":"e1575","article-title":"Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection","volume":"6","author":"Qiu","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0016","first-page":"18030","article-title":"Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques","volume":"109","author":"Olinger","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0017","first-page":"347","article-title":"CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody","volume":"8","author":"Pettit","year":"2016","journal-title":"MAbs"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0018","first-page":"5147","article-title":"Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes","volume":"111","author":"Macdonald","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0019","first-page":"5153","article-title":"Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice","volume":"111","author":"Murphy","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0020","first-page":"1418","article-title":"Emergence of Zaire Ebola virus disease in Guinea","volume":"371","author":"Baize","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0021","first-page":"S203","article-title":"Pathogenesis of experimental Ebola virus infection in guinea pigs","volume":"179","author":"Connolly","year":"1999","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0022","first-page":"8738","article-title":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection","volume":"112","author":"Pascal","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0023","first-page":"41","article-title":"Automated molecular microscopy: the new Leginon system","volume":"151","author":"Suloway","year":"2005","journal-title":"J Struct Biol"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0024","first-page":"95","article-title":"Appion: an integrated, database-driven pipeline to facilitate EM image processing","volume":"166","author":"Lander","year":"2009","journal-title":"J Struct Biol"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0025","first-page":"205","article-title":"DoG Picker and TiltPicker: software tools to facilitate particle selection in single particle electron microscopy","volume":"166","author":"Voss","year":"2009","journal-title":"J Struct Biol"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0026","first-page":"321","article-title":"Xmipp 3.0: an improved software suite for image processing in electron microscopy","volume":"184","author":"de la Rosa-Trev\u00edn","year":"2013","journal-title":"J Struct Biol"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0027","first-page":"17","article-title":"A new generation of the IMAGIC image processing system","volume":"116","author":"van Heel","year":"1996","journal-title":"J Struct Biol"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0028","first-page":"237","article-title":"Iterative stable alignment and clustering of 2D transmission electron microscope images","volume":"20","author":"Yang","year":"2012","journal-title":"Structure"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0029","first-page":"38","article-title":"EMAN2: an extensible image processing suite for electron microscopy","volume":"157","author":"Tang","year":"2007","journal-title":"J Struct Biol"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0030","first-page":"1605","article-title":"UCSF Chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0031","first-page":"17182","article-title":"Structures of protective antibodies reveal sites of vulnerability on Ebola virus","volume":"111","author":"Murin","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0032","first-page":"6739","article-title":"Ebola virus infections in nonhuman primates are temporally influenced by glycoprotein Poly-U editing site populations in the exposure material","volume":"7","author":"Trefry","year":"2015","journal-title":"Viruses"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0033","first-page":"392","article-title":"Emerging intracellular receptors for hemorrhagic fever viruses","volume":"23","author":"Jae","year":"2015","journal-title":"Trends Microbiol"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0034","first-page":"2390","article-title":"Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells","volume":"112","author":"Peipp","year":"2008","journal-title":"Blood"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0035","first-page":"20690","article-title":"Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant","volume":"108","author":"Zeitlin","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0036","first-page":"702","article-title":"Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus","volume":"75","author":"Kolokoltsov","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0037","first-page":"267","article-title":"Animal models for Ebola and Marburg virus infections","volume":"4","author":"Nakayama","year":"2013","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0038","first-page":"164","article-title":"Progression of Ebola therapeutics during the 2014\u20132015 outbreak","volume":"22","author":"Mendoza","year":"2016","journal-title":"Trends Mol Med"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0039","first-page":"1343","article-title":"Structural and molecular basis for Ebola virus neutralization by protective human antibodies","volume":"351","author":"Misasi","year":"2016","journal-title":"Science"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0040","first-page":"1664","article-title":"Epitopes involved in antibody-mediated protection from Ebola virus","volume":"287","author":"Wilson","year":"2000","journal-title":"Science"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0041","first-page":"138ra81","article-title":"Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies","volume":"4","author":"Qiu","year":"2012","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t2018112203580617700_CIT0042","first-page":"6408","article-title":"Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody","volume":"76","author":"Parren","year":"2002","journal-title":"J Virol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/218\/suppl_5\/S612\/26688936\/jiy285.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T10:22:29Z","timestamp":1589883749000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/218\/suppl_5\/S612\/5025816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,31]]},"references-count":42,"journal-issue":{"issue":"suppl_5","published-online":{"date-parts":[[2018,5,31]]},"published-print":{"date-parts":[[2018,11,22]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy285","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12,15]]},"published":{"date-parts":[[2018,5,31]]}}}